XML 40 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2017
Fair Value Disclosures [Abstract]  
Financial instruments

Note 18 - Financial instruments:

The following table summarizes the valuation of our marketable securities on a fair value basis as of December 31, 2016 and 2017:

 

 

Fair value measurements

 

 

Total

 

 

Quoted

prices

in active

markets

(Level 1)

 

 

Significant

other

observable

inputs

(Level 2)

 

 

Significant

unobservable

inputs

(Level 3)

 

 

(In thousands)

 

December 31, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities

$

49,731

 

 

$

49,731

 

 

$

-

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities

$

88,681

 

 

$

88,681

 

 

$

-

 

 

$

-

 

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure as December 31, 2016 and 2017:

 

 

December 31, 2016

 

 

December 31, 2017

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Carrying

Amount

 

 

Fair

Value

 

 

(In thousands)

 

Cash, cash equivalents and restricted cash

$

98,242

 

 

$

98,242

 

 

$

102,941

 

 

$

102,941

 

Noncontrolling interest in CompX common stock

 

16,350

 

 

 

26,790

 

 

 

17,756

 

 

 

22,224

 

The fair value of our noncontrolling interest in CompX stockholders’ equity is based upon its quoted market price at each balance sheet date, which represents Level 1 inputs.  Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value.